文献速递儿科与产科急症重症综合管理与镇静镇痛

接受体外膜氧合儿童用药暴露模式:优先未来药理学研究的一步

Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies.
PubMed 文献 · Crit Care Explor · 2019-09-16
一句话结论单中心回顾性研究显示,接受体外膜氧合(ECMO)的儿童累计用药暴露随支持时间增加,仅40%常用药物有文献支持、20%有剂量指导。

该单中心回顾性研究分析了2014年10月1日至2018年9月30日在费城儿童医院ICU接受ECMO支持的254名儿科患者的用药情况,按年龄组(<1月、1月至<2岁、2至<12岁、>12岁)和ICU类型(心脏、新生儿、儿科)描述药物暴露。共使用179种不同药物,累计药物暴露从插管后1周的中位数10种(四分位6-14)增至5周的31种(21-45),不同年龄组和ICU间总药物暴露有显著差异。对50种最常用药物的药代动力学/药效学文献回顾发现,排除体外研究后仅40%(20/50)有文献支持使用,20%(10/50)有剂量指导且主要基于模拟和聚焦新生儿和婴儿的回顾性研究。研究强调未来需开展药代动力学/药效学研究,剂量指南对优化ECMO危重患儿治疗至关重要。

要点

  • 254名ECMO儿童共使用179种不同药物,累计暴露从1周中位数10种(6-14)增至5周31种(21-45)。
  • 不同年龄组和ICU类型间总药物暴露有显著差异。
  • 50种最常用药物中,排除体外研究后仅40%(20/50)有文献支持使用。
  • 仅20%(10/50)常用药物有剂量指导,主要基于模拟和聚焦新生儿和婴儿的回顾性研究。

适用人群与场景

  • 2014年10月1日至2018年9月30日在费城儿童医院ICU接受ECMO支持的儿科患者。

研究设计与关键结果

  • 回顾性单中心研究,纳入254名接受ECMO的儿科患者,共使用179种不同药物。
  • 累计药物暴露从插管后1周的中位数10种(四分位6-14)增至5周31种(21-45)。
  • 不同年龄组和ICU间总药物暴露有显著差异。
  • 50种最常用药物中,排除体外研究后,仅40%(20/50)有文献支持使用;20%(10/50)有剂量指导,主要基于模拟和聚焦新生儿和婴儿的回顾性研究。

证据类型、等级与局限

  • 回顾性单中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该研究凸显了未来药代动力学/药效学研究的特定需求,剂量指南对优化ECMO危重患儿治疗至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To identify medications administered to pediatric patients on extracorporeal membrane oxygenation and to review the available pharmacokinetics and pharmacodynamics literature for the most commonly administered medications.

DESIGN: Retrospective single-center study.

SETTING: ICUs at Children's Hospital of Philadelphia.

PATIENTS: Pediatric patients supported by extracorporeal membrane oxygenation between October 1, 2014, and September 30, 2018.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Drug exposure was described according to age group (< 1 mo, 1 mo to < 2 yr, 2 to < 12 yr, and > 12 yr) and ICU (cardiac, neonatal, pediatric). The association of drug exposure with patient's characteristics was examined using one-way analysis of variance for categorical variables and linear regression for continuous variables. All pharmacokinetics and pharmacodynamics literature for the 50 most commonly administered medications on extracorporeal membrane oxygenation was reviewed, with inclusion of studies that reported dosing regimens in conjunction with pharmacokinetics or pharmacodynamics data. A total of 179 different medications were administered to 254 children. Cumulative drug exposure increased with the duration of extracorporeal membrane oxygenation from a median (interquartile) of 10 drugs (6-14) at 1 week to 31 drugs (21-45) at 5 weeks following cannulation. There were significant differences in total drug exposure between age groups and ICUs. With exclusion of in vitro studies, published literature was available to support the use of 40% (20/50) of the most commonly administered medications. Dosing guidance was available for 20% (10/50) of medications and was primarily based on simulations and retrospective studies focusing on neonates and infants.

CONCLUSIONS: This study highlights specific needs for future pharmacokinetics and pharmacodynamics studies. Dosing guidelines are essential to optimize the care of critically ill children supported by extracorporeal membrane oxygenation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Thibault C, Collier H, Naim MY, et al. Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies. Crit Care Explor. 2019. PMID: 32166287. doi:10.1097/CCE.0000000000000045

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。